ICON Public Limited Company (ICLR)
NASDAQ: ICLR · Real-Time Price · USD
133.14
-11.41 (-7.89%)
At close: Feb 11, 2026, 4:00 PM EST
133.81
+0.67 (0.50%)
After-hours: Feb 11, 2026, 6:30 PM EST
ICLR Revenue
ICON Public Limited Company had revenue of $2.04B in the quarter ending September 30, 2025, with 0.63% growth. This brings the company's revenue in the last twelve months to $8.10B, down -2.46% year-over-year. In the year 2024, ICON Public Limited Company had annual revenue of $8.28B with 1.99% growth.
Revenue (ttm)
$8.10B
Revenue Growth
-2.46%
P/S Ratio
1.31
Revenue / Employee
$193,380
Employees
41,900
Market Cap
10.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.28B | 161.50M | 1.99% |
| Dec 31, 2023 | 8.12B | 378.79M | 4.89% |
| Dec 31, 2022 | 7.74B | 2.26B | 41.24% |
| Dec 31, 2021 | 5.48B | 2.68B | 95.93% |
| Dec 31, 2020 | 2.80B | -8.55M | -0.30% |
| Dec 31, 2019 | 2.81B | 210.06M | 8.09% |
| Dec 31, 2018 | 2.60B | 837.34M | 47.62% |
| Dec 31, 2017 | 1.76B | 91.95M | 5.52% |
| Dec 31, 2016 | 1.67B | 91.51M | 5.81% |
| Dec 31, 2015 | 1.57B | 71.66M | 4.77% |
| Dec 31, 2014 | 1.50B | 167.26M | 12.52% |
| Dec 31, 2013 | 1.34B | 221.05M | 19.83% |
| Dec 31, 2012 | 1.12B | 169.28M | 17.90% |
| Dec 31, 2011 | 945.73M | 45.69M | 5.08% |
| Dec 31, 2010 | 900.04M | 12.43M | 1.40% |
| Dec 31, 2009 | 887.61M | 22.36M | 2.58% |
| Dec 31, 2008 | 865.25M | 234.53M | 37.18% |
| Dec 31, 2007 | 630.72M | 175.13M | 38.44% |
| Dec 31, 2006 | 455.60M | -13.99M | -2.98% |
| May 31, 2005 | 469.58M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Labcorp Holdings | 13.77B |
| Quest Diagnostics | 11.04B |
| Illumina | 4.34B |
| Charles River Laboratories International | 4.02B |
| Waters | 3.17B |
| Exact Sciences | 3.08B |
| Revvity | 2.86B |
| Medpace Holdings | 2.36B |
ICLR News
- 15 days ago - ICON's Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership - Business Wire
- 16 days ago - GreensKeeper Value Fund Q4 2025 Portfolio Update: Long-Term Winners - Seeking Alpha
- 2 months ago - ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive - Business Wire
- 2 months ago - ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions - Business Wire
- 2 months ago - ICON Public Limited Company (ICLR) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 months ago - ICON plc to Present at the Jefferies London Healthcare Conference - Business Wire
- 3 months ago - Invesco International Small-Mid Company Fund Q3 2025 Top Contributors And Detractors - Seeking Alpha
- 3 months ago - ICON Public Limited Company (ICLR) Q3 2025 Earnings Call Transcript - Seeking Alpha